Pharmaceutical Business Intelligence Reports
Showing 613–624 of 709 results
-
Excipient Business Development Opportunity Reports
TRAGACANTH Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRELEGY ELLIPTA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRELSTAR Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TREXIMET Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRI-LUMA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
TRIACETIN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
TRIETHYL CITRATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRIJARDY XR Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRIKAFTA (COPACKAGED) Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRILIPIX Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
TRIPTODUR KIT Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
TRISODIUM CITRATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart
